Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 1.000 | |
| 4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.592 | |
| 2cjm | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.546 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.541 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.530 | |
| 4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.529 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.519 | |
| 2cci | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.503 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.492 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.492 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.484 | |
| 4s33 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.483 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.478 | |
| 4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.478 | |
| 4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.477 | |
| 5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.477 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.476 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.474 | |
| 1ig1 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.473 | |
| 3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.465 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.463 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.461 | |
| 1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
| 1jst | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
| 3llt | ANP | Protein serine/threonine kinase-1 | / | 0.458 | |
| 2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.457 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.457 | |
| 4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.455 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.455 | |
| 4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.452 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
| 5ap7 | SVE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.450 | |
| 4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.448 | |
| 4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.448 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.448 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.447 | |
| 4ifc | ADP | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.446 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
| 3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 1zp9 | ATP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.442 |